193 related articles for article (PubMed ID: 37631968)
21. Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: protocol for an observational cohort study (LongCOVID-study).
Mutubuki EN; van der Maaden T; Leung KY; Wong A; Tulen AD; de Bruijn S; Haverman L; Knoop H; Franz E; van Hoek AJ; van den Wijngaard CC
BMJ Open; 2022 Jul; 12(7):e062439. PubMed ID: 35777877
[TBL] [Abstract][Full Text] [Related]
22. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
23. The Prevalence of Irritable Bowel Syndrome after Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Their Association: A Systematic Review and Meta-Analysis of Observational Studies.
Wang Z; Peng Y; Chen M; Peng L; Huang Y; Lin W
J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902651
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis.
Luo D; Mei B; Wang P; Li X; Chen X; Wei G; Kuang F; Li B; Su S
Clin Microbiol Infect; 2024 Mar; 30(3):328-335. PubMed ID: 37866679
[TBL] [Abstract][Full Text] [Related]
25. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
26. Post-infection functional gastrointestinal disorders following coronavirus disease-19: A case-control study.
Ghoshal UC; Ghoshal U; Rahman MM; Mathur A; Rai S; Akhter M; Mostafa T; Islam MS; Haque SA; Pandey A; Kibria MG; Ahmed F
J Gastroenterol Hepatol; 2022 Mar; 37(3):489-498. PubMed ID: 34672022
[TBL] [Abstract][Full Text] [Related]
27. Characterisation of the long-term physical and mental health consequences of SARS-CoV-2 infection: A systematic review and meta-analysis protocol.
Kuodi P; Gorelik Y; Edelstein M
PLoS One; 2022; 17(4):e0266232. PubMed ID: 35381027
[TBL] [Abstract][Full Text] [Related]
28. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of oral manifestations in COVID-19: A systematic review.
Sharma P; Malik S; Wadhwan V; Gotur Palakshappa S; Singh R
Rev Med Virol; 2022 Nov; 32(6):e2345. PubMed ID: 35271738
[TBL] [Abstract][Full Text] [Related]
30. The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the literature.
Chaudhry ZS; Nellessen N; Reis C; Sharip A
Fam Pract; 2022 Nov; 39(6):1116-1134. PubMed ID: 35395090
[TBL] [Abstract][Full Text] [Related]
31. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis.
Ceban F; Ling S; Lui LMW; Lee Y; Gill H; Teopiz KM; Rodrigues NB; Subramaniapillai M; Di Vincenzo JD; Cao B; Lin K; Mansur RB; Ho RC; Rosenblat JD; Miskowiak KW; Vinberg M; Maletic V; McIntyre RS
Brain Behav Immun; 2022 Mar; 101():93-135. PubMed ID: 34973396
[TBL] [Abstract][Full Text] [Related]
32. [The gastrointestinal effects of COVID–19 infection during childhood and among the children affected with inflammatory bowel disease].
Tóbi L; Prehoda B; Balogh A; Dezsőfi-Gottl A; Cseh Á
Orv Hetil; 2022 Feb; 163(6):214-221. PubMed ID: 35124570
[TBL] [Abstract][Full Text] [Related]
33. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
34. Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution.
Robineau O; Zins M; Touvier M; Wiernik E; Lemogne C; de Lamballerie X; Blanché H; Deleuze JF; Saba Villarroel PM; Dorival C; Nicol J; Gomes-Rima R; Correia E; Coeuret-Pellicer M; Druesne-Pecollo N; Esseddik Y; Ribet C; Goldberg M; Severi G; Carrat F;
JAMA Netw Open; 2022 Nov; 5(11):e2240985. PubMed ID: 36350653
[TBL] [Abstract][Full Text] [Related]
35. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey.
Oshima T; Siah KTH; Yoshimoto T; Miura K; Tomita T; Fukui H; Miwa H
J Gastroenterol Hepatol; 2021 Jul; 36(7):1820-1827. PubMed ID: 33197076
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Symptoms ≤12 Months After Acute Illness, by COVID-19 Testing Status Among Adults - United States, December 2020-March 2023.
Montoy JCC; Ford J; Yu H; Gottlieb M; Morse D; Santangelo M; O'Laughlin KN; Schaeffer K; Logan P; Rising K; Hill MJ; Wisk LE; Salah W; Idris AH; Huebinger RM; Spatz ES; Rodriguez RM; Klabbers RE; Gatling K; Wang RC; Elmore JG; McDonald SA; Stephens KA; Weinstein RA; Venkatesh AK; Saydah S;
MMWR Morb Mortal Wkly Rep; 2023 Aug; 72(32):859-865. PubMed ID: 37561663
[TBL] [Abstract][Full Text] [Related]
37. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
38. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis.
Di Mascio D; Khalil A; Saccone G; Rizzo G; Buca D; Liberati M; Vecchiet J; Nappi L; Scambia G; Berghella V; D'Antonio F
Am J Obstet Gynecol MFM; 2020 May; 2(2):100107. PubMed ID: 32292902
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and clinical presentation of long COVID in children: a systematic review.
Pellegrino R; Chiappini E; Licari A; Galli L; Marseglia GL
Eur J Pediatr; 2022 Dec; 181(12):3995-4009. PubMed ID: 36107254
[TBL] [Abstract][Full Text] [Related]
40. Two-month follow-up of persons with SARS-CoV-2 infection-Zambia, September 2020: a cohort study.
Zulu JE; Banda D; Hines JZ; Luchembe M; Sivile S; Siwingwa M; Kampamba D; Zyambo KD; Chirwa R; Chirwa L; Malambo W; Barradas D; Sinyange N; Agolory S; Mulenga LB; Fwoloshi S
Pan Afr Med J; 2022; 41():26. PubMed ID: 35291364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
